The IPO will include both fresh issuances and an offer for sale. Credit: kenary820/Shutterstock.

India’s Niva Bupa Health Insurance Company (Niva Bupa) is preparing for an IPO, with the aim of garnering $361.54m (Rs30.04bn), reported the the Economic Times (ET), citing sources. 

The health insurer is a joint venture (JV) between UK-based British United Provident Association (Bupa) and Indian private equity investor True North. 

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Sources told the publication that Niva Bupa has hired investment bankers such as Kotak Mahindra Capital, ICICI Securities and Morgan Stanley to manage the IPO. 

Currently, Bupa holds a 63% stake in the JV, while True North has a 28% share.  

The remaining ownership is split between other financial investors and employees, holding 7% and 2%, respectively.  

The IPO will include both fresh issuances and an offer for sale, although details of the proportions have not been disclosed. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

One of the sources was quoted by the publication as saying: “The health insurer has enlisted the services of three bankers for its Rs30bn public issue, primarily aimed at augmenting equity capital to ensure the solvency ratio remains above the regulatory requirements.” 

According to ET,  Niva Bupa is among the top stand-alone health insurance providers in the country and a key player in the overall health insurance market in India.  

The company’s product portfolio includes critical illness, personal accident and overseas medical insurance policies.  

An email seeking Niva Bupa’s comments on the matter did not draw a response. 

In September 2023, True North agreed to sell a 20% stake in Niva Bupa to Bupa for approximately Rs27bn.  

This stake was originally acquired by True North from Max in 2019.